Cobro Ventures — Full Portfolio

3 tracked investments · listed companies and verified rows first

AI Proteinsaiproteins.bioin 𝕏Jul 2023SEC filingmedium confidence

AI Proteins designs engineered miniproteins for drug discovery and development in the biopharmaceutical industry.

AI & Machine LearningBiotechDeep TechAndover, US

Dominique Verhelle(Director)Bill McKee(Director)Julia Novina(Executive Officer)Marc A. Cohen(Executive Officer, Director)Geoff Meyerson(Director)Elena Prokupets(Director)

Board seatTodd Kaloudis· per SEC Form D · $10M raise · filed Aug 2023

Microbial Machines, Inc.Apr 2022SEC filingmedium confidence

BiotechAndover, US

Drew Dennison(Chief Executive Officer)Bobby Sandage(Director)Carl Novina(Director)Jeffrey Wagner(Chief Scientific Officer)Tom Erickson(Director)Julia A. Novina(Chief Legal Officer)

Board seatTodd Kaloudis· per SEC Form D · $13.9M raise · filed May 2022

NextRNA TherapeuticsJan 2022SEC filingmedium confidence

BiotechCambridge, US

Carl Novina(Director)Elena Prokupets(Director)Barry Polisky(Director)Andrea Armstrong(Director)Dominique Verhelle(Director)Marc A. Cohen(Executive Officer, Director)

Board seatArthur Becker· per SEC Form D · $50M raise · filed Jan 2022

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.